<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZOC5PL2N</identifier><date>2005</date><creator>Rozman, Tanja</creator><creator>Sollner Dolenc, Marija</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-zoc5pl2n.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-zoc5pl2n.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-zoc5pl2n.txt</relation><format format_type="issue">4</format><format format_type="volume">56</format><format format_type="main">7 strani</format><format format_type="type">article</format><format format_type="extent">str. 221-228</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">1870449</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZOC5PL2N</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">gripa</subject><subject language_type_id="slv">inhibitorji</subject><subject language_type_id="slv">nevraminidaza</subject><subject language_type_id="slv">oseltamivir</subject><subject language_type_id="slv">sialidaza</subject><subject language_type_id="slv">zanamivir</subject><title>Gripa in inhibitorji virusne nevraminidaze</title></Record>